| Oct 23 |
CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM
|
| Sep 23 |
Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference
|
| Sep 12 |
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
|
| Sep 11 |
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
|
| Aug 22 |
Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients
|
| Aug 20 |
Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients
|
| Aug 20 |
Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now
|
| Aug 14 |
Cadrenal Therapeutics to Present at Upcoming Investor Conferences
|
| Aug 12 |
Cadrenal Therapeutics, Inc. (CVKD): A New Penny Stock to Buy Now
|
| Jul 17 |
Cadrenal Therapeutics to Present at the Emerging Growth Conference on July 18, 2024
|
